Studies have been carried out to investigate aspects of the structure of thrombomodulin, an endothelial cell glycoprotein that binds thrombin and accelerates both the thrombin-dependent activation of protein C and the inhibition of antithrombin III. We have determined the shape of Solulin TM , a soluble recombinant form of human thrombomodulin missing the transmembrane and cytoplasmic domains, by electron microscopy of preparations rotary-shadowed with tungsten. Solulin appears to be an elongated molecule about 20 nm long that has a large nodule at one end and a smaller nodule near the other end from which extends a thin strand. About half of the molecules form bipolar dimers apparently via interactions between these thin strands. Electron microscopy of complexes formed between Solulin and human ␣-thrombin revealed that a single thrombin molecule appears to bind to the smaller nodule of Solulin, suggesting that this region contains the epidermal growth factor-like domains 5 and 6. Epidermal growth factor-like domains 1-4 comprise the connector between the small and large nodule, which is the lectin-like domain; the thin strand at the other end of the molecule is the carbohydrate-rich region. With chondroitin sulfatecontaining soluble thrombomodulin produced from either human melanoma cells Bowes or Chinese hamster ovary cells, a higher percentage of molecules bound thrombin and, in some cases, two thrombin molecules were attached to one soluble thrombomodulin in approximately the same region. These structural studies provide insight into the structure of thrombomodulin and its interactions with thrombin as well as aspects of the mechanisms of its actions.
Human thrombomodulin is a single chain glycoprotein made up of 557 amino acids, as well as N-and O-linked carbohydrate, that acts as a co-factor in the activation of protein C by thrombin and a modulator for the specificity of thrombin (1) (2) (3) (4) (5) (6) . From analysis of the amino acid sequence, thrombomodulin is made up of five regions, a lectin-like domain, a group of six epidermal growth factor-like modules, a serine-, threonine-, and O-glycosylation-rich region, a transmembrane sequence, and a cytoplasmic domain. There is, however, little information on the spatial arrangement of these domains.
In its actions as an anticoagulant, thrombomodulin has several functions: the binding of thrombin, resulting in the modulation of its substrate specificity; a co-factor in the activation of protein C; and a co-factor in the inhibition of thrombin by antithrombin III (1, 2, 4 -6) . The binding of thrombomodulin to thrombin effectively destroys the specificity of this enzyme for catalyzing the conversion of fibrinogen to fibrin, the activation of factors V, VIII, and XIII, and the activation of platelets. At the same time, in the presence of calcium ions, thrombomodulin acts as a co-factor for the activation of protein C, which, together with protein S, inactivates factor Va and VIIIa, thereby suppressing the generation of thrombin. The binding of thrombomodulin to thrombin plays a key role in controlling an allosteric switch between two forms of thrombin (2, 7, 8) . Free thrombin clots fibrinogen well but activates protein C poorly, while thrombin bound to thrombomodulin clots fibrinogen poorly but activates protein C rapidly. The antithrombotic functions of the thrombomodulin-protein C system are important for the prevention of thromboembolic disease. Patients with protein C or protein S deficiency or defects develop thromboembolic disease. A patient with thromboembolic disease and a point mutation in thrombomodulin has been identified and studied (9) . There have also been studies indicating that a soluble form of thrombomodulin may be useful in the prevention of venous thrombosis (10 -12) . In addition, thrombomodulin appears to be necessary for normal embryonic development in utero. The absence of thrombomodulin causes embryonic lethality in mice before the development of a functional cardiovascular system (13) .
The chondroitin sulfate moieties attached to thrombomodulin affect some of its binding interactions and functions. Chondroitin sulfate is required for the modulation of the inhibition of thrombin by antithrombin III, since chondroitin sulfate-free thrombomodulin has no effect on the rate of formation of the complex of thrombin and antithrombin III (14, 15) . The presence of chondroitin sulfate also increases the affinity of soluble thrombomodulin for thrombin (16, 17) . The interactions of thrombin with the chondroitin sulfate on thrombomodulin were studied by titrating fluorescently labeled thrombin and thrombomodulin with or without chondroitin sulfate (18) . It was found that the first thrombin bound to the 5th and 6th epidermal growth factor-like domains, and one or more additional molecules of thrombin bound more weakly to the chondroitin sulfate. The modulation of glycosaminoglycan addition that is naturally expressed in various cell lines has been investigated (19) . In addition, site-directed mutagenesis was used to study the requirements for the inclusion of chondroitin sulfate on thrombomodulin.
In the work described in this paper, electron microscopy of rotary-shadowed preparations was carried out to reveal the shape of a soluble form of thrombomodulin and allow spatial identification of its functional regions. Complexes of soluble thrombomodulin, either containing or lacking chondroitin sul-fate, formed with thrombin were also examined by electron microscopy. Knowledge of the shape of thrombomodulin and localization of its structural and functional domains should provide insight into the mechanisms of its actions.
EXPERIMENTAL PROCEDURES
Human thrombomodulin derivatives were genetically engineered in CHO 1 cells or CHL-1 cells and purified as previously reported (19 -21) . The soluble recombinant thrombomodulin lacking chondroitin sulfate used in these studies was a mutated form of TM LEO (19, 20) 474 3 Ala, and deletion of the last 7 amino acids of the carboxyl terminus (22) . Solulin from CHO cells was prepared by anion exchange chromatography and affinity chromatography on an inactivated thrombin column (19, 21) . Chondroitin sulfate-containing soluble thrombomodulin or TM LEO (CSϩ) with the Met 388 3 Leu mutation was prepared from CHL-1 cells by repeated anion exchange chromatography on QSepharose columns (19, 20) and from CHO cells by anion exchange and affinity chromatography (19, 21) . Human ␣-thrombin was a generous gift of Dr. John Fenton, II (State University of New York, Albany, NY).
Thrombomodulin samples for electron microscopy were initially at a concentration of 1.84 mg/ml in 0.2% N-ethylmorpholine, pH 7.5; thrombin was at a concentration of about 0.31 mg/ml in the same buffer. Solulin was incubated with different molar ratios of thrombin (usually 1:1, 2:1, or 1:2) for 1-2 h at 37°C. Samples were then diluted to a concentration of about Ϸ25 g/ml into a volatile buffer (usually 0.05 M ammonium formate at pH 7.4) and 70% glycerol.
Rotary-shadowed specimens were prepared by quickly spraying this dilute solution of molecules onto freshly cleaved mica and shadowing with a light coat of tungsten in a vacuum evaporator (Denton Vacuum Co., Cherry Hill, NJ) (23) (24) (25) . All of the specimens were examined in a Philips 400 electron microscope (Philips Electronic Instruments Co., Mahwah, NJ) usually operating at 80 kV and a magnification of ϫ 60,000. All experiments were repeated a number of times, and large numbers of specimens were examined and photographed randomly to ensure that the results were reproducible and to minimize the selection of nonrepresentative images. Measurements of the sizes of observed structural features are reported as mean Ϯ S.D., including the number of particles measured (n), and have been corrected for the layer of metal shadow.
RESULTS
Electron Microscopy of Soluble Thrombomodulin-Electron microscopy of rotary-shadowed proteins dried in the presence of glycerol has allowed the visualization of a wide variety of proteins with relatively few artifacts, because glycerol appears to protect against distortion during drying (26). However, visualization by electron microscopy of proteins with molecular mass as low as that of thrombomodulin requires careful attention to the details of specimen preparation. Tungsten was used for the experiments described here because it has a slightly smaller grain size than platinum.
Some typical images of soluble thrombomodulin (Solulin) are shown in Fig. 1, a and b . The gallery of images here and in the other figures illustrates the variety of appearances. The most commonly observed structure was an elongated rod with a large nodule at one end and a smaller nodule near the other end. In some images (Ϸ10%) a thin strand extended from the smaller nodule. The average length of the structures from the end of the large nodule to end of the small nodule was 16.0 Ϯ 3.0 nm (n ϭ 255) after correction for the layer of metal. The total length of these structures including the thin strand was about 20 -21 nm. The larger end globular region had a diameter of 5.1 Ϯ 1.5 nm, while the smaller nodule was 3.0 Ϯ 1.5 nm. A few molecules appeared to be curved or bent ( Fig. 1 ), but most were fairly straight.
About one-third of the images were trinodular with a length of 31.0 Ϯ 3.5 nm (Fig. 1, c and d) . In these images, the end nodules had the same appearance and size as the larger of the two nodules in the shorter structures, and the central nodule was slightly smaller in size. Occasionally it was apparent that the central nodule was made up of two smaller nodules, each with the same size as that of the small nodule in the shorter structures. In conclusion, the longer structures appear to be dimers of the shorter ones. In most cases, the two molecules interact in a bipolar fashion, pointing in opposite directions 180°apart, such that there is a large nodule at each end. Occasionally dimers at angles other than 180°were observed (Fig. 1d, far right) . Since there were about twice as many monomers as dimers, approximately one-half of the molecules appear to be in the monomeric form and one-half in the dimeric form. It should be noted that Ͼ95% of the images were consistent with the features described for either the monomer or the dimer.
The length of the dimers that exhibited two nodules readily discernible in the central region (33 nm) was such that the small nodules were barely touching at their distal ends. In many other images of the dimers, there was probably a little more overlap at the ends, since the total average length (31 nm) was slightly less than twice the distance from large to small nodule in the monomer. In conclusion, the interactions in the dimers apparently occur via either the strands extending from the small nodule or the distal ends of the small nodules themselves.
Electron Microscopy of Soluble Thrombomodulin with Thrombin Bound-Molecules of ␣-thrombin were prepared for electron microscopy in the same way as the Solulin. Nearly 99% of the images of the thrombin molecules revealed an approximately circular structure with a diameter of about 5 nm, in agreement with results of the x-ray crystallographic structure determination showing a structure 4.5 ϫ 4.5 ϫ 5.0 nm (7, (27) (28) (29) (30) . A field of molecules is shown in Fig. 2 . Many images of thrombin also reveal the cleft across the middle of the globular molecule that is known to exist from x-ray crystallographic studies.
Solulin was incubated with thrombin and samples were rotary-shadowed for electron microscopy. Some examples are shown in Fig. 3 . Most images revealed a dumbbell-like structure 17.5 Ϯ 2.2 nm long with a large nodule at each end. Occasionally, visualization of the thin strand that normally is associated with the small nodule of Solulin allowed the two ends to be differentiated. More often, the presence of a cleft in one of the nodules allowed it to be identified as thrombin. The cleft was commonly within about 30°of being perpendicular to the long axis of the soluble thrombomodulin. In other words, thrombin binds with a specific orientation near the end of the Solulin where the smaller nodule is located. At molar ratios of thrombin to Solulin of 1:1 or 2:1 most images had this appearance. Less than 10% of structures observed had the appearance of the bipolar dimers seen with Solulin alone, although there were some free thrombin and monomeric Solulin molecules.
Electron Microscopy of Thrombin with Chondroitin Sulfatecontaining Soluble Thrombomodulin-Chondroitin sulfatecontaining soluble thrombomodulin molecules were produced in CHL-1 cell and CHO cells. Rotary-shadowed chondroitin sulfate-containing soluble thrombomodulin molecules were not noticeably different in appearance than Solulin, although a thin strand arising from the smaller nodule was apparent in more images (data not shown).
Chondroitin sulfate-containing molecules were incubated with thrombin as described above and then prepared for electron microscopy. Most images of the complexes were identical to those for thrombin with Solulin lacking chondroitin sulfate described in the previous section, i.e. dumbbell-shaped structures containing a single nodule at each end (data not shown). On the other hand, there were also many structures consisting of a single nodule at one end and two nodules at the other end (Fig. 4) , indicating that the chondroitin sulfate-containing soluble thrombomodulin molecules could bind either one or two thrombin molecules. There was no apparent difference in appearance or thrombin binding characteristics between the chondroitin sulfate-containing soluble thrombomodulin molecules from the CHL-1 cells (Fig. 4, a and b) or from the CHO cells (Fig. 4, c and d) .
In some experiments, the numbers of free soluble thrombomodulin molecules and thrombomodulin/thrombin complexes were counted. Under identical conditions, with a molar ratio of soluble thrombomodulin to thrombin of 1:1, 65% of soluble thrombomodulin molecules with chondroitin sulfate had one or more thrombins bound, while 47% of Solulin lacking chondroitin sulfate had one thrombin molecule bound.
DISCUSSION
The Shape of Thrombomodulin-In the electron microscope studies presented here, we have visualized a soluble form of thrombomodulin known as Solulin. This molecule had an elongated or extended structure with a 5-nm globular domain at one end, a central connecting rod about 8 nm long, and followed by a smaller nodule. In some images, a thin strand extended from the smaller nodule. The Solulin used for these experiments contained the lectin domain and the epidermal growth factor-like domains, as well as the sequences containing Olinked sugars, but was missing the transmembrane sequence and the cytoplasmic domain.
In the images of complexes of Solulin and thrombin, it was apparent that thrombin obscured the smaller nodule, indicating that it binds in this region. From the average of measurements of distances in the images of Solulin/thrombin complexes, the distance from the end of the large nodule to the center of the thrombin was 15.5 nm, while the distance to the center of the small nodule in Solulin was 14.5 nm. Since it is known that thrombin binds to the 5th and 6th epidermal growth factor (EGF) domains (31) and to the chondroitin sulfate moiety in the carbohydrate-rich region (32, 33) , these parts of thrombomodulin must be located in or near the small nodule.
These results, together with a large array of other information in the literature (1, 2, 5, 6), allow us to identify the locations of some of the domains of thrombomodulin in the electron microscope images. The large nodule can be identified as the lectin-like domain at the amino-terminal end of the molecule because of its size and location at one end of the structures observed. Next in the sequence come the EGF-like domains. The structures of several EGF modules, including EGF 4 from thrombomodulin (3, 34) , are known from either x-ray crystallographic or NMR studies; they are 3.5 ϫ 1.5 ϫ 1.5 nm in size. The length of a series of EGF modules depends on their orientation in space and the size of the connectors between them. In fibulin, for example, 9 EGF modules are 18 nm long (35) . Thus, the 4 of them making up EGF 1-4 of thrombomodulin would typically span a distance of about 8 nm, which is the length of the connector between the large and small nodule. Because the centers of the small nodule and thrombin nearly coincide, the small nodule must contain the thrombin-binding sites on EGF domains 5 and 6. Because we observed a compact nodule in this region, it appears likely that EGF domains 5 and 6 interact with each other strongly, as has been shown for the two EGF domains in protein C (36) . It is possible that the small nodule also contains part of EGF domain 4, which is necessary for protein C activation, although it is not involved in thrombin binding.
Some images of Solulin revealed a thin strand extending from the small nodule. This structure, which has approximately the same appearance as the connector of the ␣C domains of fibrinogen (37) or the ends of high molecular weight kininogen (38) , is just at the limit of resolution that can be detected in proteins that have been rotary-shadowed with tungsten. Therefore, it was not seen in all images of Solulin. Nevertheless, we propose that these strands represent the extended O-linked carbohydrate-rich region of Solulin based on other evidence related to the topology of thrombomodulin. Fluorescence energy transfer measurements of active site-labeled thrombin in thrombin-thrombomodulin complexes have demonstrated that the active site of thrombin is 6.5 Ϯ 0.3 nm above the membrane surface (39) . Identification of the thin strand as the carbohydrate-rich region would put the center of thrombin at about 6 nm from the transmembrane domain of thrombomodulin. Our hypothesis is thus consistent with the fluorescence energy transfer measurements within the margin of error associated with these electron microscope measurements and the lack of information on the orientation of thrombin in the thrombin-thrombomodulin complex. With this model, thrombin would also extend slightly beyond the small nodule of thrombomodulin, allowing for interactions of the anion-binding exosite II of thrombin with the chondroitin sulfate moiety in the carbohydrate-rich region of thrombomodulin.
The appearance of soluble thrombomodulin molecules was similar whether or not they contained chondroitin sulfate, but in the latter case the thin strand containing the chondroitin sulfate was visible in more images. The chondroitin sulfatecontaining form of soluble thrombomodulin purified from CHL-1 cells has one or two chondroitin sulfate chains attached (19) , in contrast to Solulin, which has a mutated chondroitin sulfate attachment site. Glycosaminoglycans have been visualized by electron microscopy on some proteoglycans, including the heavily substituted rat chondrosarcoma proteoglycan to which Ͼ100 chondroitin sulfate and keratan sulfate chains are attached (40) and on mouse Engelbreth-Holm-Swarm tumor basement membrane proteoglycan, which has five heparan sulfate chains (41) . In these specimens shadowed with platinum the individual polysaccharide chains were near the limit of detection. Although we are using tungsten for shadowing, which increases the resolution slightly, mass spectral analysis of soluble thrombomodulin from CHL-1 cells indicates that its chondroitin sulfate chains are short, consisting of 15 disaccharide units or less. 2 The effect of the chondroitin sulfate on the images of soluble thrombomodulin thus appears to be a slight enhancement of visibility of the thin strand that contains the polysaccharides.
A model for the spatial organization of domains in thrombomodulin is shown schematically in Fig. 5a . Starting at the amino-terminal end, the first 223 residues make up the lectinlike domain, which is Ϸ5 nm in diameter and would be farthest from the membrane surface. This nodule is about the size expected for this mass of protein, especially when allowance is made for the contribution of carbohydrate to its apparent size and the possibility that it is not spherical but has a more complex shape that would contain a smaller volume. The rod connecting the large and small nodules appears to be made up 2 T. A. Young, unpublished data. of EGF-like modules 1-4. Because the average number of amino acids in each EGF module and connectors is about 40 and each module is 3.5 ϫ 1.5 ϫ 1.5 nm in size, the length of this rod is consistent with the proposed composition. The small nodule is made up of EGF modules 5-6 and possibly part of 4; its diameter of Ϸ3 nm is consistent with its mass. The thin strand projecting from the end of the small nodule is the Olinked carbohydrate-rich domain. It is normally 34 residues long, but 6 residues of this domain are missing from Solulin. The length of such a polypeptide chain will depend on its folding, which is unknown but could certainly span the observed 4 -5 nm. However, such a thin strand would not ordinarily be visible in rotary-shadowed preparations, except for the presence of the carbohydrate moieties. The membranespanning domain consists of 23 residues, and the cytoplasmic domain consists of 38 residues. Neither of these were present in the soluble thrombomodulin visualized in these experiments but are represented in the schematic diagram.
The Solulin molecules were either straight or slightly bent. Molecules with the sort of bend suggested in one earlier model (42) were not seen. Although some evidence indicates that the lectin-like domain may interact with lipid vesicles (32), interactions of the lectin-like domain with the cell membrane do not appear likely from our observations of the shape of thrombomodulin.
Approximately two-thirds of the images of Solulin were monomers, while one-third were dimers interacting via their end regions containing the thin strand and small nodule. That is, about one-half of the molecules were interacting to form the dimers. The length of the dimers was consistent with the interactions occurring via the thin strand and/or the distal ends of the small nodule. This dimerization could involve carbohydrate-carbohydrate or carbohydrate-protein interactions in the carbohydrate-rich region. There were very few dimers of Solulin in the presence of an equimolar ratio of thrombin, suggesting that the thrombin interactions at this end of Solulin interfere with the dimerization.
This dimerization could indicate a potential for clustering of thrombomodulin molecules in the membrane. The aggregation of Solulin observed here suggests that the carbohydrate-rich regions tend to interact with each other, although the bipolar orientation of the dimers would only occur with Solulin in vitro without the constraints of the membrane.
Sedimentation equilibrium experiments in the analytical ultracentrifuge showed that detergent-solubilized thrombomodulin molecules exist as a nonequilibrating mixture of monomer and oligomers (43) . The maximum amount of monomer never exceeded 20% of the total mass and in one preparation was less than 1%. In all experiments, 50 -80% of protein was aggregated to oligomers regardless of the detergent concentration. The lack of fractionation by gel filtration chromatography indicates that the detergent micelle dominates the particle size, but the resistance of the oligomers to dissolution at higher detergent concentrations suggests that the thrombomodulin aggregates are quite stable within the detergent micelle. The strength and prevalence of these interactions suggests that they may have some functional relevance. Electron microscopy of endothelial cells with labeled thrombomodulin do in fact show clustering of the receptors (44, 45) . The physiological relevance of this receptor clustering is not clear, although it may be related to internalization of thrombomodulin. In any case, the formation of Solulin dimers via the carbohydrate-rich regions could suggest a mechanism for the observed clustering.
Interactions of Thrombomodulin with Thrombin-Rotaryshadowed thrombin molecules appear to be approximately circular with a diameter of about 5 nm, consistent with the results of the x-ray crystallographic structure determination, which revealed an almost spherical molecule with dimensions 4.5 ϫ 4.5 ϫ 5.0 nm (7, (27) (28) (29) (30) . The striking cleft or canyon in thrombin that contains the substrate binding pocket is visible in some of the rotary-shadowed molecules, probably depending on the molecular orientation and perhaps the details of the shadowing.
␣-Thrombin, which contains 295 amino acids, is about the same size as the larger nodule of thrombomodulin. Thus, since thrombin binds to the smaller nodule, the complex of Solulin and thrombin appears to be a dumbbell with nodules of approximately equal size at each end. The individual thrombin molecule in the complex can be identified in some images where the thin strand that extends from the small nodule is visible. More often, thrombin can be identified by its cleft. Where this cleft is visible, it is usually oriented approximately perpendicular to the long axis of the Solulin molecule.
EGF modules 5-6 interact with anion-binding exosite I on thrombin (31), but EGF modules 4 -6 are necessary to accelerate protein C activation (46 -49) . In addition, the Arg-Gly-Asp triplet in thrombin appears to be involved in thrombomodulin interactions (50) . Alanine-scanning mutagenesis has shown which residues of the EGF modules are critical for these interactions (51) , and x-ray crystallographic and NMR studies have determined the three-dimensional structure of thrombin with a subdomain from the EGF region of thrombomodulin bound (52, 53) .
A schematic diagram of thrombomodulin with thrombin bound is shown in Fig. 5b . Note that the distance of the active site of thrombin above the membrane surface is about the same as that shown by fluorescence energy transfer (18) . As pointed out by Esmon (2) , the similarity of this distance above the membrane to that of a variety of other complexes of clotting factors suggests that the catalysis of these proteins may be further enhanced by the alignment of the active site of an enzyme with the bond cleaved. In addition, it has been shown that deletion of the O-linked carbohydrate domain dramatically decreased both thrombin binding and the co-factor activity of membrane-bound thrombomodulin, which demonstrates the importance of this spacer above the membrane (48) . Substitutions of this domain with chains of decreasing length and without glycosylation sites progressively decreased thrombin binding and co-factor activity.
The chondroitin sulfate of thrombomodulin has distinctive effects on its interactions with thrombin, including accelerated reaction of thrombin with antithrombin III and enhanced blocking of procoagulant functions (2, 32, 33) . Like heparin, the chondroitin sulfate probably interacts with the anion-binding exosite II on thrombin. Chondroitin sulfate also influences the calcium ion dependence of protein C activation. The dissociation constant for thrombin and Solulin or any other chondroitin sulfate-free form of soluble thrombomodulin that contains all six EGF-like domains is 3-5 nM (16, 21) . There is a 5-10-fold increase in thrombin affinity for soluble thrombomodulin when chondroitin sulfate is attached (16, 17) . In our experiments with soluble thrombomodulin containing chondroitin sulfate, we observed an increase in the percentage of thrombin complexes compared to experiments with Solulin, which lacks the chondroitin sulfate, consistent with the higher affinity of thrombin for chondroitin sulfate-containing thrombomodulin.
In addition, we observed many soluble thrombomodulin molecules that had bound two thrombins in close proximity to each other. Previous studies have shown that the chondroitin sulfate moieties bind one or more thrombins (18) . These results are in agreement with our images, since the chondroitin sulfate binding sites are in close proximity to the high affinity thrombinbinding site on epidermal growth factor domains 5 and 6. Furthermore, we observed a higher percentage of complexes of thrombin with soluble thrombomodulin containing chondroitin sulfate. However, we have never observed more than two thrombin molecules bound to a single thrombomodulin. It appears that either there is only a single site on the chondroitin sulfate or steric hindrance prevents more than one thrombin from binding at any time. A schematic diagram of thrombomodulin with two thrombin molecules bound is shown in Fig. 5c .
In conclusion, thrombomodulin is an elongated protein made up of globular and rodlike regions. The thrombin-binding site has been localized to a small nodule in the middle of the native molecule. The spatial features of thrombomodulin defined by these studies provide some limitations on any models for the molecular mechanisms involved in the various functions of this molecule in hemostasis, thrombosis, and inflammation. In addition, the molecular shape of thrombomodulin may provide some insight into the actions of other related membrane proteins such as the low density lipoprotein receptor (54) .
